In the 1960’s and 70’s‚ Albert Humphrey is said to have developed this strategic planning tool using data from the top companies in America at the time. A SWOT Analysis looks at the strengths‚ weaknesses‚ opportunities and threats that are relevant to an organization in a new venture. A SWOT Analysis is a tool which allows users to look at the direction a company or organization may wish to move towards in the future. A SWOT Analysis is a useful tool‚ which in conjunction with others can help make
Premium Pharmaceutical industry SWOT analysis Drug discovery
EXECUTIVE SUMMARY Global Pharma Industry is likely to grow at a CAGR of 5% to US $ 1 Trillion by 2013 The Pharmaceuticals Industry in India is the world’s 3 largest in terms of volume and stands 14th in terms of sale. Domestic pharma sector benefitted from increased thrust on Rural Health through bigger budgetary allocations in the Budget of 2009-10 According to PWC in 2010‚ India joined the league of Top 10 global pharmaceutical markets in terms of sales by 2020 with value reaching
Premium Pharmaceutical industry Generic drug
|The Pharmaceutical Industry | |Consolidated Paper | | | Table of Contents Introduction 3 Macro-Environmental Challenges 3 Political Challenges within the Macro-Environment 5 Economic Challenges within the Macro-Environment 8 Social Challenges within the Macro-Environment 11 Technological
Premium Pharmaceutical industry Pharmacology Generic drug
PHARMACEUTICAL INDUSTRY ANALYSIS Industry Background: The total industry can broadly be classified into two categories. These are a) Patent Medicines b) Generic Medicines Patent medicines are the products that are invented by the company‚ who have their own research team working on their own laboratories. These products are patented for many years to enjoy the monopoly market. After years of business the formulation is sold in the market so that others can go into mass production. Generic
Premium Pharmaceutical industry Pharmacology
Global Pharmaceutical Industry Analysis September 21 2009 Dibakar Mitra (P08017) I Manoj Joshi (B08026) Table of Contents EXECUTIVE SUMMARY 3 INTRODUCTION 4 ORIGIN AND EVOLUTION 5 ENVIRONMENT ANALYSIS (PEST) 7 STRUCTURAL INDUSTRY ANALYSIS (PORTER) 8 STRATEGIC ISSUES FACING THE INDUSTRY 11 STRATEGIC GROUPS IN THE INDUSTRY ACCORDING TO MARKET/DRUG/FUNCTIONING 15 PROCESS FLOW: IMPORTANT FUNCTIONS 16 STRATEGIC RESPONSES TO CHALLENGES: SIMPLE CORRELATION BETWEEN GROUP
Premium Pharmaceutical industry
State intervention in the pharmaceutical industry: social advance or threat to innovation? By Ivan Topalovic Introduction 1/ The Product A/ European level‚ the “EMEA” B/ R.O.W. a) The Followers b) The non-Followers 2/ The Price A/ Worldwide parameters B/ Examples of price fixing per country 3/ The Place 4/ The Promotion Conclusion Appendix I Chronology in therapeutic innovation Appendix II Major pharmaceutical companies mergers / acquisitions
Premium Pharmacology Clinical trial Generic drug
ETHICAL ISSUES IN THE PHARMACEUTICAL INDUSTRY Ethical Issues in the Pharmaceutical Industry Abstract No one can deny that the pharmaceutical industry has made significant contributions to human progress. The pharmaceutical industry has been responsible for drugs that have saved millions of lives‚ cured many forms of cancer‚ and ensured that an AIDS diagnosis is no longer an automatic death sentence. Yet despite this there are questions that the public has on whether the industry has been fulfilling
Premium Physician Clinical trial Pharmaceutical industry
A Look at Data Mining in the Pharmaceutical Industry Topics Covered: 1) What is Data Mining and why is it used? 2) How is Data Mining used in the Pharmaceutical Industry? 3) Recent debate in the legality of Data Mining and the Pharmaceutical Industry Pharmaceutical companies are taking advantage of the growing use of technology in the healthcare arena by using data to enhance their marketing efforts and increase the quality of research and development. The process of data mining
Premium Data mining Pharmaceutical industry Pharmacology
YRH: Pharmaceutical Industry in China to 2020 Market Overview‚ Size‚ Share‚ Analysis‚ Technology Developments‚ Development Status‚ Trends‚ Structure‚ Production Value and Forecast Research Report Summary “Pharmaceutical Industry in China to 2020: An In Depth Analysis of Multinational and Chinese Biopharma Companies‚ Industry Trends‚ Environment‚ Regulation‚ Market Drivers‚ Restraints‚ Opportunities & Challengess” provides a detailed investigation of the market size‚ segmentation‚ key players‚ SWOT
Premium Pharmacology Pharmaceutical industry Food and Drug Administration
STRATEGIC ANALYSIS OF THE WORLD PHARMACEUTICAL INDUSTRY Dragan Kesič∗ Received: 28. 2. 2007 Case study Accepted: 9. 7. 2008 UDC 65.01:615 The world pharmaceutical industry has been changing profoundly in the last decade. Intensive globalization‚ increased competitiveness and the fight for global market shares create new challenges for pharmaceutical companies. Fast globalization definitively reinforces the consolidation of the world pharmaceutical industry. Alliancing in forms of mergers and
Premium Pharmaceutical industry Generic drug Marketing